Michelle H. Townsend

801 total citations
27 papers, 551 citations indexed

About

Michelle H. Townsend is a scholar working on Oncology, Molecular Biology and Epidemiology. According to data from OpenAlex, Michelle H. Townsend has authored 27 papers receiving a total of 551 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 14 papers in Molecular Biology and 9 papers in Epidemiology. Recurrent topics in Michelle H. Townsend's work include Biochemical and Molecular Research (8 papers), CAR-T cell therapy research (7 papers) and Cytomegalovirus and herpesvirus research (7 papers). Michelle H. Townsend is often cited by papers focused on Biochemical and Molecular Research (8 papers), CAR-T cell therapy research (7 papers) and Cytomegalovirus and herpesvirus research (7 papers). Michelle H. Townsend collaborates with scholars based in United States. Michelle H. Townsend's co-authors include Kim L. O’Neill, Richard A. Robison, Gajendra Shrestha, Stephen Piccolo, K. Scott Weber, Michael Anderson, Alyssa Parker, Matthew J. Heaton, Wei Meng and Erica Suh and has published in prestigious journals such as PLoS ONE, Cancer Research and Experimental Cell Research.

In The Last Decade

Michelle H. Townsend

26 papers receiving 543 citations

Peers

Michelle H. Townsend
Kien Pham United States
Chandtip Chandhasin United States
Christopher Silvin United States
Ameeta A. Patel United States
Aitian Li China
Kien Pham United States
Michelle H. Townsend
Citations per year, relative to Michelle H. Townsend Michelle H. Townsend (= 1×) peers Kien Pham

Countries citing papers authored by Michelle H. Townsend

Since Specialization
Citations

This map shows the geographic impact of Michelle H. Townsend's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle H. Townsend with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle H. Townsend more than expected).

Fields of papers citing papers by Michelle H. Townsend

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michelle H. Townsend. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle H. Townsend. The network helps show where Michelle H. Townsend may publish in the future.

Co-authorship network of co-authors of Michelle H. Townsend

This figure shows the co-authorship network connecting the top 25 collaborators of Michelle H. Townsend. A scholar is included among the top collaborators of Michelle H. Townsend based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michelle H. Townsend. Michelle H. Townsend is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Townsend, Michelle H., et al.. (2023). TK1 expression influences pathogenicity by cell cycle progression, cellular migration, and cellular survival in HCC 1806 breast cancer cells. PLoS ONE. 18(11). e0293128–e0293128. 2 indexed citations
2.
Townsend, Michelle H., et al.. (2022). Tumor Microenvironment Immunosuppression: A Roadblock to CAR T-Cell Advancement in Solid Tumors. Cells. 11(22). 3626–3626. 45 indexed citations
3.
Townsend, Michelle H., et al.. (2021). Overexpression and surface localization of HPRT in prostate cancer provides a potential target for cancer specific antibody mediated cellular cytotoxicity. Experimental Cell Research. 403(1). 112567–112567. 8 indexed citations
4.
Shrestha, Gajendra, Michelle H. Townsend, Bradford K. Berges, et al.. (2020). Novel monoclonal antibodies against thymidine kinase 1 and their potential use for the immunotargeting of lung, breast and colon cancer cells. Cancer Cell International. 20(1). 127–127. 8 indexed citations
5.
Townsend, Michelle H., et al.. (2020). Thymidine kinase 1 through the ages: a comprehensive review. Cell & Bioscience. 10(1). 138–138. 82 indexed citations
6.
Townsend, Michelle H., et al.. (2020). Paving the way towards universal treatment with allogenic T cells. Immunologic Research. 68(1). 63–70. 22 indexed citations
8.
Townsend, Michelle H., et al.. (2020). Hypoxanthine Guanine Phosphoribosyltransferase expression is negatively correlated with immune activity through its regulation of purine synthesis. Immunobiology. 225(3). 151931–151931. 9 indexed citations
9.
Townsend, Michelle H., et al.. (2020). Macrophage Toll-Like Receptor Chimeric Antigen Receptor: MOTO-CAR™ Shows Potent Activation and Killing of Triple Negative Breast Cancer Cells. ScholarsArchive (Brigham Young University).
10.
Townsend, Michelle H., et al.. (2019). Potential new biomarkers for endometrial cancer. Cancer Cell International. 19(1). 19–19. 37 indexed citations
11.
Townsend, Michelle H., Richard A. Robison, & Kim L. O’Neill. (2018). A review of HPRT and its emerging role in cancer. Medical Oncology. 35(6). 89–89. 57 indexed citations
12.
Townsend, Michelle H., Erica Suh, Stephen Piccolo, et al.. (2018). Membrane expression of thymidine kinase 1 and potential clinical relevance in lung, breast, and colorectal malignancies. Cancer Cell International. 18(1). 135–135. 27 indexed citations
13.
Townsend, Michelle H., Gajendra Shrestha, Richard A. Robison, & Kim L. O’Neill. (2018). The expansion of targetable biomarkers for CAR T cell therapy. Journal of Experimental & Clinical Cancer Research. 37(1). 163–163. 67 indexed citations
14.
Robinson, David M., et al.. (2018). Characterization of two related Erwinia myoviruses that are distant relatives of the PhiKZ-like Jumbo phages. PLoS ONE. 13(7). e0200202–e0200202. 13 indexed citations
15.
Townsend, Michelle H., et al.. (2017). Non-small-cell lung cancer cell lines A549 and NCI-H460 express hypoxanthine guanine phosphoribosyltransferase on the plasma membrane. OncoTargets and Therapy. Volume 10. 1921–1932. 53 indexed citations
16.
Townsend, Michelle H., et al.. (2017). Evaluation of various glyphosate concentrations on DNA damage in human Raji cells and its impact on cytotoxicity. Regulatory Toxicology and Pharmacology. 85. 79–85. 27 indexed citations
17.
Meng, Wei, Michelle H. Townsend, Michael Boyer, et al.. (2017). Biomarker analysis and clinical relevance of TK1 on the cell membrane of Burkitt’s lymphoma and acute lymphoblastic leukemia. OncoTargets and Therapy. Volume 10. 4355–4367. 12 indexed citations
18.
Townsend, Michelle H., et al.. (2017). Elevated Expression of Hypoxanthine Guanine Phosphoribosyltransferase within Malignant Tissue. ScholarsArchive (Brigham Young University). 6(2). 19–19. 20 indexed citations
19.
Townsend, Michelle H., et al.. (2017). Abstract 1949: Salvage pathway enzyme HPRT as a molecular marker for Burkitt’s Lymphoma. Cancer Research. 77(13_Supplement). 1949–1949. 1 indexed citations
20.
Townsend, Michelle H., et al.. (2017). Metastatic colon adenocarcinoma has a significantly elevated expression of IL-10 compared with primary colon adenocarcinoma tumors. Cancer Biology & Therapy. 19(10). 913–920. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026